🏢CompaniesFortress Biotech Reports Q3 Revenue of $19 Million, Outlines Growth Path for Dermatology Portfolio
Fortress Biotech posted $19 million in third-quarter 2026 revenue while highlighting clinical and commercial progress for its dermatology treatments.